Search results
Moderna sees positive results in COVID-flu vaccine trial
The Hill via Yahoo News· 3 days agoModerna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Los Angeles· 3 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC Miami· 3 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 3 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoAt the moment, Moderna’s Spikevax vaccine for Covid-19 is used in the NHS booster programmes,...
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA Today· 2 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. For the two-week period ...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 6 days agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine ...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 21 hours agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...